Free
Infographics in Anesthesiology  |   May 2018
Reducing Harm from Opioids: New Approaches for a Pressing Problem
Author Notes
  • Vanderbilt University Medical Center
  • Brigham and Women’s Health Care/Harvard Medical School
  • Illustration by Annemarie Johnson, Vivo Visuals.
    Illustration by Annemarie Johnson, Vivo Visuals.×
  • Address correspondence to Dr. Wanderer: jonathan.p.wanderer@vanderbilt.edu.
Article Information
Infographics in Anesthesiology / Pain Medicine / Pharmacology / Opioid
Infographics in Anesthesiology   |   May 2018
Reducing Harm from Opioids: New Approaches for a Pressing Problem
Anesthesiology 5 2018, Vol.128, A19. doi:10.1097/ALN.0000000000002224
Anesthesiology 5 2018, Vol.128, A19. doi:10.1097/ALN.0000000000002224
Complex Information for Anesthesiologists Presented Quickly and Clearly
ED = emergency department; GI = gastrointestinal.
Infographic created by Jonathan P. Wanderer, Vanderbilt University Medical Center, and James P. Rathmell, Brigham and Women’s Health Care/Harvard Medical School. Illustration by Annemarie Johnson, Vivo Visuals. Address correspondence to Dr. Wanderer: jonathan.p.wanderer@vanderbilt.edu.
Soergel, DG, Subach, RA, Burnham, N, Lark, MW, James, IE, Sadler, BM, Skobieranda, F, Violin, JD, Webster, LR Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Pain 2014; 155:1829–35 [Article] [PubMed]
Lee, JD, Nunes, EVJr, Novo, P, Bachrach, K, Bailey, GL, Bhatt, S, Farkas, S, Fishman, M, Gauthier, P, Hodgkins, CC, King, J, Lindblad, R, Liu, D, Matthews, AG, May, J, Peavy, KM, Ross, S, Salazar, D, Schkolnik, P, Shmueli-Blumberg, D, Stablein, D, Subramaniam, G, Rotrosen, J Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial. Lancet 2018; 391:309–18 [Article] [PubMed]
Ohia-Nwoko, O, Kosten, TA, Haile, CN Animal models and the development of vaccines to treat substance use disorders. Int Rev Neurobiol 2016; 126:263–91 [Article] [PubMed]
D’Onofrio, G, Chawarski, MC, O’Connor, PG, Pantalon, MV, Busch, SH, Owens, PH, Hawk, K, Bernstein, SL, Fiellin, DA Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: Outcomes during and after intervention. J Gen Intern Med 2017; 32:660–6 [Article] [PubMed]